A QT/QTc Evaluation Study of TS-142 in Healthy Adult Subjects

Clinical trial NCT04873323 · COMPLETED

Trial details

NCT number: NCT04873323
Sponsor: Taisho Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2021-06-07
Primary completion: 2021-09-28
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.